Blood disorders and blood cancers are treated by doctors from the Division of Hematology/Oncology – the largest subspecialty unit within the Department of Internal Medicine.
In concert with the University of Michigan Rogel Cancer Center, we care for patients with benign and malignant disorders of the blood and lymphatic organs. Our multidisciplinary team of experts is on the leading edge of research and is committed to providing patients with the very best care and treatment.
Some people with kidney cancer don’t have symptoms, or any known risk factors, and often kidney tumors are found accidentally when a test (like a CT scan or MRI) is done for another reason. This can catch people by surprise - especially if they don't feel sick.
Symptoms of Kidney Cancer
Blood in urine (may make look rusty or darker red)
A risk factor is anything that affects your chance of getting a disease, such as cancer. There are different kinds of risk factors. Some factors, like a person's age or race, can't be changed. Others are linked to cancer-causing factors in the environment. Still others are to related personal behaviors, such as smoking, drinking, and diet. Some factors influence risk more than others, and your risk for kidney cancer can change over time, due to factors such as aging or lifestyle.
Kidney Cancer is among the 10 most common cancers in both men and women
Renal cell carcinoma (RCC), also known as renal cell cancer or renal cell adenocarcinoma, is by far the most common type of kidney cancer. About 9 out of 10 kidney cancers are renal cell carcinomas.
The University of Michigan Rogel Cancer Center is built on a foundation of comprehensive, integrated and interdisciplinary specialty care. Although a colorectal cancer patient may not see each member of the team, all of the specialists listed below are involved in reviewing patients’ cases and recommending a treatment plan that is coordinated and tailored to the individual patient.
Researchers used the proton pump inhibitor omeprazole, a commonly used acid inhibitor, in combination with naproxen and found it was effective at preventing bladder cancer in an animal model.